Etaracizumab

• CAT Number: I042423
• CAS Number: 892553-42-3
• Molecular Weight: 144.3 (kDa)
• Purity: ≥95%

Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1].

Reference

[1]. Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or – dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34.
 [Content Brief]